Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Head & Neck 5Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 630Head and Neck Neoplasms 609Carcinoma, Non-Small-Cell Lung 201Thyroid Neoplasms 196Melanoma 145Nasopharyngeal Carcinoma 133Oropharyngeal Neoplasms 130Colorectal Neoplasms 127Mouth Neoplasms 126Neoplasms 112Breast Neoplasms 112Lung Neoplasms 106Ovarian Neoplasms 104Uterine Cervical Neoplasms 99Neoplasm Metastasis 93Carcinoma, Squamous Cell 85Carcinoma, Renal Cell 83Stomach Neoplasms 82Triple Negative Breast Neoplasms 76Pancreatic Neoplasms 71Esophageal Neoplasms 69Laryngeal Neoplasms 68Endometrial Neoplasms 65Urinary Bladder Neoplasms 59Sarcoma 57Thyroid Cancer, Papillary 54Prostatic Neoplasms 52Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 46Carcinoma, Hepatocellular 45

Interventions

pembrolizumab 1Imiquimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Leukoplakia × Head & Neck × 1 year × Clear all
NCT07596355 2026-05-19

H&NANCE

Istituto Italiano di Tecnologia

Not yet recruiting
283 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Leukoplakia, Neoplasms

NCT07210775 2026-03-04

Topical Imiquimod Treatment of Oral Dysplasia

University of Southern California

Phase 1/2 Recruiting
20 enrolled
DermatologicHead & Neck

Leukoplakia, Leukokeratosis, Hereditary Mucosal

NCT05323292 2025-12-17

Vitamin A Status in Patients With Vocal Fold Leukoplakia

University of Wisconsin, Madison

Enrolling by invitation
90 enrolled
Head & Neck

Leukoplakia, Vitamin A Deficiency

NCT00341497 2025-07-31

Biomarkers for Oral Cancer

National Institutes of Health Clinical Center (CC)

Completed
80 enrolled
Head & Neck

Leukoplakia, Leukoplakia, Oral, Lichen Planus, Mouth Neoplasms

NCT03603223 2025-07-30

Pembrolizumab in Treating Participants With Leukoplakia

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
26 enrolled
Head & Neck

Leukoplakia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡